Feed IXC.AX
IX
Invex Therapeutics Ltd
IXC.AX · ASX
$0.12 +0.00% (+$0.00)
1M +15.00%
Market Cap $8.6M
P/E Ratio -
Div. Yield -
ROE 8.82%
Bulios Fair Price
$0.08
30.4% downside
Aktuální cena
$0.12
Podhodnoceno Férová hodnota Nadhodnoceno
Podle Bulios Fair Price je akcie IXC.AX aktuálně nadhodnocená vůči své tržní ceně. Jak to funguje?
Valuation
48 /100
Fair P/B 1.65x
P/S 37.73x
P/FFO N/A
Growth
45 /100
Stable Book val. growth 43.10%
Rev. growth 7.92%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 309.63%
Gross margin 100.00%
FCF margin 284.86%
Quality
0 /100
Poor ROA 8.72%
ROIC 13.52%
Asset turnover 0.04x
Debt
100 /100
Low Current ratio 24.79x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
22 /100
Unstable EPS volatility 95.19%
Beta 0.53x
Profitable years 0
Zeptejte se StockBota na IXC.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Ryan Slate
Employees
4
Headquarters
Subiaco
Nadcházející události
13 SRP
Earnings
Upcoming earnings report